27–30 November 2018
DNA Methylation Data Analysis Workshop
The purpose of this workshop is to get a deeper understanding of the use of bisulfite-treated DNA in order to analyze the epigenetic layer of DNA methylation. Advantages and disadvantages of the so-called 'bisulfite sequencing' and its implications on data analyses will be covered. The participants will be trained to understand bisulfite-treated NGS data, to detect potential problems/errors and finally to implement their own pipelines. After this course they will be able to analyze DNA methylation and create ready-to-publish graphics.
8–9 November 2018
4th Annual Genome Editing Congress 2018
London, United Kingdom
Gene Editing is the future of therapy. Join Oxford Global for the 4th Annual Genome Editing Congress (https://www.oxfordglobal.co.uk/genomeediting-congress/ ) as our panel of over 20 world class speakers discuss the latest gene editing technologies, gene delivery systems and gene therapy applications.
Our esteemed speaker list features Zoltán Ivics, Head of Division, Paul Ehrlich Institute, presenting on non-viral genome editing transposon vectors, and Adriana Beltran, Director Human Pluripotent Stem Cell Core, University of North Carolina Chapel Hill who will provide insights on CRISPR stem cell models of genetic disease.
Putting you in contact with over 600 senior level delegates, this is the number one industry event for scientific networking with leading genome editing experts.
The event is co-located with our 10th Annual Next Generation Sequencing & Clinical Diagnostics Congress, our 6th Annual Single Cell Analysis Congress and Synthetic Biology Congress.
Download the congress agenda here: https://www.oxfordglobal.co.uk/genomeediting-congress/download-agenda/
Alternatively contact Danielle Dalby on [email protected]
29–31 October 2018
International Plant Epi/Genetics Symposium 2018
“Plant epi/genetics” is an international conference on epigenetics and transposable elements. The aim of this conference is to bring together experts, novices, students and breeders to exchange and discuss their latest results in the fields of epigenetics and transposable elements. The conference will range from fundamental research to applications in crop plants. Plant breeding companies are encouraged to join in and participate at this meeting.
Thanks to kind sponsors, we'll have poster and presentation prizes for PhD students.
The main themes of the conference will be:
- Epigenetic and genetic mechanisms involved in genome stability.
- Transposable elements and plant genome evolution.
- Heritability of epigenetic marks.
- Regulation of phenotypic variability in plants by transposable elements and epigenetics
- Harnessing epigenetics and transposable elements for crop breeding.
- Novel sequencing technologies and bioinformatics tools for the analysis of epigenetic marks and transposable elements.
- Isabel Bäurle
- Claude Becker
- Tetsuji Kakutani
- Marie Mirouze
- Olivier Panaud
- Bob Schmitz
- Nathan Springer
- Clémentine Vitte
- Jian-Kang Zhu
We hope to meet you in Angers soon!
for the organizing committee
14–17 October 2018
EMBO Workshop-From epigenome towards epitranscriptome in cell fate choice
This EMBO Workshop involves sessions dedicated to recent advances in the epigenomic and epitranscriptomic regulation of stem cell pluripotency and differentiation, organismal development, and how their alteration brings about human diseases. Particular emphasis on approaches enabling targeted manipulation of epigenetic marks, which are revolutionising the field, will be addressed. Topics to be covered include: 1. Dynamic DNA and RNA modifications: Writers, erasers, and readers. 2. Decoding the function of DNA and RNA modifications: Insights from epigenome editing and other approaches. 3. DNA and RNA Epigenetics in Stem Cell and Development. 4. Epigenomes and Epitranscriptomes: A gateway to understanding diseases.
9–12 October 2018
3rd Danube Conference on Epigenetics
Following the success of the previous Epigenetic Conferences in Budapest (2012, 2014 and 2016) we are delighted to announce that the next Danube Conference on Epigenetics will be held October 9-12th, 2018 again in Budapest. The conference is organized by Tamás Arányi (RCNS, HAS, Hungary), Bálint L. Bálint (University of Debrecen, Hungary), Petra Hajkova (MRC London Institute of Medical Sciences, UK), J. Andrew Pospisilik (Max Planck Institute of Immunobiology and Epigenetics, Germany) and Laszlo Tora (IGBMC, France).
The main objectives are to bring scientists together from the fields of epigenetics and promote intensive interdisciplinary interactions facilitated by the medium sized meeting. Therefore the conference program is structured to have a lot of networking opportunity.
30 September–3 October 2018
5th Canadian Conference on Epigenetics
Estérel Resort, Estérel, Quebec, Canada
The Canadian Epigenetics, Environment and Health Research Consortium Network is organizing the 5th annual Canadian Conference on Epigenetics to be held from September 30-October 3, 2018 in Estérel, Quebec. This symposium is intended to bring together a critical mass of epigenetics researchers, along with key international leaders in the field, to engage in cross-disciplinary dialogue on recent advancements in the field of epigenomics with a focus on the impact of epigenetic mechanisms in human disease. This symposium will be held at the Estérel Resort in Estérel, QC, just one and a half hours from Montreal. There will be several sessions over the course of the three days including presentations by key international and Canadian speakers.
18–21 September 2018
The Fourth Shanghai International Workshop of Epigenetics in Development and Diseases
We are proud to announce the Fourth Shanghai International Workshop of
Epigenetics and Diseases/The 13th Annual Conference of Asian Epigenome
Alliance, which will take place between 18th and 21st, Sept, 2018 in
Shanghai. The scientific program consists of six plenary sessions, each
consisting of six 25 minutes oral presentations, respectively:
1. Chemical and Biological Perspectives of DNA Modifications,
2. Chemical and Biological Perspectives of Histone Modifications,
3. Chemical and Epigenetic Perspectives of Transcription,
4. Clinical Epigenetics,
5. Chemical and Biological Perspectives of the Higher-order Chromatin
6. Developmental Epigenetics.
In addtion，two poster sessions and 12 10 minutes talks in total will selected from the submitted posters.
24–27 February 2018
Neuroepigenetics and Neuroepitranscriptomics Conference
Epigenetic mechanisms — including DNA and histone modifications, as well as regulation by non-coding RNAs — have pivotal roles in the nervous system. Aberrant epigenetic regulation also contributes to pathogenesis in various brain disorders. There are a number of recent ground-breaking discoveries of new features of epigenetic marks and regulation that are enriched in the nervous system, leading to an emerging new field of “neuroepigenetics”. In addition, new discoveries of modification of mRNAs and long non-coding RNAs lead to a new field of “epitranscriptomics”. This meeting will bring together experts and pioneers in studying neuroepigenetics and epitranscriptomics to provide an up-to-date and comprehensive picture of epigenetic and epitranscriptomic mechanisms in neural development, reprogramming and cell identity, plasticity, neuronal function and dysfunction. The meeting will offer opportunity for interdisciplinary interactions and future collaborations.
15–18 February 2018
Epigenetics Conference From Mechanisms to Disease
The DNA of eukaryotic cells is organized into chromatin fibres, where the nucleosome is the basic repeating unit. Chromatin is thus at the core of fundamental processes such as gene regulation, stem cell fate determination and cancer. By and large, these topics have traditionally been covered by separated meetings. However, recent literature indicates that the boundaries among these various disciplines are becoming less clear. This meeting on "Epigenetics: from mechanisms to disease" will bring together scientists studying chromatin architecture, epigenetics, stem cell biology and cancer. The talks will cover a broad range of topics, including chromosome organisation, long-range interactions, chromatin assembly, stem cell regulation/differentiation, RNA-based mechanisms and transcription regulation. Speakers have been selected to broadly reflect lessons learned from a variety of model organisms and experimental approaches. Young scientists will be able to present their work through a large number of short talks selected from submitted abstracts as well as through poster presentation. The program has also allocated ample time for exchanging ideas and discussing novel hypotheses at the end of each session, as well as time for informal interactions and networking.
29 October–1 November 2017
Dear Colleagues, The Australian Epigenetics Alliance (AEpiA) is a professional association for people engaged in Epigenetic research throughout Australia. The aim of the Australian Epigenetics Alliance is to unite the facilitate communication among all Australian research groups interested in epigenetics –based question. The membership comprises people from a broad range of fields from basic plant and model organism research, through livestock and agriculture research, to human disease diagnosis, prognosis and therapy. In the 21st century, epigenetics is transcending genetics to be at the forefront of research into development, disease states, ecology, and evolution. Our 2017 program will showcase: The convening committee is hard at work to ensure the program is comprehensive, providing something for all researchers from all areas of the life science- from basic plant and model organism research, through livestock and agriculture research, to human disease diagnosis, prognosis and therapy. Session topics include: Epigenetic Therapies and Biomarkers Development and Inheritance Epigenetic Mechanisms Functional Epigenomics Epigenetics and Disease Epitranscriptome International Faculty include: Prof Peter Jones, Van Andel Institute, Michigan Prof Stephen Baylin, John Hopkins, Baltimore
25–26 October 2017
Epigenetic Mechanisms in Health and Disease. Barcelona Conference on Epigenetics and Cancer
Among the most important challenges in biomedicine is to understand the role of chromatin and epigenetics in human health and disease. During last 15 years, epigenetics has consolidated as a new multi-disciplinary field on its own with an enormous scientific and therapeutic potential for cancer and many other relevant human pathologies such as cardiovascular diseases, aging, neurodegenerative diseases and diabetes. “Epigenetic mechanisms in health and disease” is the last of a series of Barcelona Conferences on Epigenetics and Cancer (BCEC). The 2017 edition is co-organized by B·Debate, an initiative of Biocat and "la Caixa" Foundation, and the Molecular Biology Institute of Barcelona (IBMB-CSIC), together with Josep Carreras Leukemia Research Institute (IJC). The scientific program has been put together by Albert Jordan, Ferran Azorin, Marian Martínez-Balbas, Jordi Bernuès and Marcus Buschbeck. The aim of the BCEC 2017 is to bring together young and established scientists in an interdisciplinary forum to review the progress made in the field of epigenetics. Presentations will highlight the translation of basic research into clinical applications and discuss still unexploited fundamental insights. We will cover topics including stem cell biology, development, leukemia and nuclear organization.
12–13 October 2017
3rd Annual Epigenetics Discovery Congress
After our two successful editions, we are glad to announce the 3rd Annual Epigenetics Discovery Congress, which will be taking place on the 12th - 13th of October 2017 in London, UK. With a tremendous progress in technology to generate and analyze reference epigenomes, the epigenetics field is fetching a lot of importance and attention across all medical science’s areas. Additionally, novel epigenetic molecules across many target classes for drug discovery, have been the prime focus of the pharmaceutical industry. To meet and support this pace of the epigenetics research and development field, the 3rd Annual Epigenetics Discovery Congress will present novel research and address challenges right from molecular sciences & disease diagnosis to drug discovery streams. The congress will also be a great platform to learn about novel technologies like next generation sequencing and single cell analysis.
28–30 August 2017
Transgenerational Epigenetic Inheritance: Impact for Biology and Society
The Latsis Symposium 2017 is motivated by the wish and strong need to discuss and debate about the novel field of transgenerational epigenetic inheritance, an emerging discipline that is currently revolutionizing biology and is bringing novel perspectives for medical research and the society. The field addresses a key question in biology: What mediates heredity. While it was thought to have been resolved by genetics, this question has re-emerged in the post-genomic era because of the recognition that there is more to an organism than its gene sequences. The question is considered one of the most burning and urgent to answer to date. The main aim of the Latsis 2017 symposium is to discuss the breadth of biological phenomena involving epigenetics and their importance for transgenerational inheritance. The conference focuses on the issue of cross- and trans-generational inheritance of traits acquired by environmental exposure and personal experiences, a major mode of transmission that works outside classical Mendelian inheritance. Epigenetics is one of the most active and vibrant disciplines in biomedical research. It is of key importance because it not only provides new fundamental knowledge about basic mechanisms of biology but it also addresses critical medical issues. The identification of epigenetic marks and processes such as DNA methylation, histone posttranslational modifications and non-coding RNAs are moving the understanding of biological functions forward. Large-scale mapping projects have started to provide increasingly rich descriptions of the epigenome but have still incompletely answered questions about the role of these biochemical marks. Meanwhile there is growing interest in the therapeutic potential of epigenetic drugs that can modulate the epigenetic landscape and possibly have therapeutic actions that other drugs do not have. Genes encoding proteins that read, write or erase epigenetic marks are often mutated in neurological, psychiatric and metabolic diseases and in cancer, and are therefore key targets for potential innovative treatments. The conference will combine presentations from leaders in the field of epigenetics and epigenetic inheritance related to behavior, metabolism and physiology in humans and animal models, from mental health and epidemiology to bioinformatics and ethics. It will address the question of how epigenetic processes mediate the impact of experiences across one or multiple generations. Germline and non-germline modes of transmission and challenges for DNA methylation, chromatin modifications and ncRNAs as mechanisms of epigenetic inheritance will be discussed. The inherent difficulties of this challenging discipline and the innovative approaches that can address these difficulties will be critically discussed. The program includes lectures, short presentations and poster sessions. It also includes a public lecture (in German) discussing how epigenetics can change our view on health. This public lecture is open to everyone (academics, journalists and any citizen).